Case Report

Medication safety and rare side effect of carbamazepine: A case report


Introduction: Medicines are the most widely used interventions in health care and adverse drug reactions alone are responsible for 5-10% of hospitalizations in elderly patients. Carbamazepine is an anticonvulsant drug and skin rash is one of its rare symptoms of it. It requires immediate medical attention and is sometimes life-threatening.
Case Report: This case report is about a 72-year-old woman who witnessed the interaction of rivaroxaban and carbamazepine, and the side effects of carbamazepine simultaneously.
Conclusion: Patient participation and patient-centered tools are needed to promote patient safety.

1. World Patient Safety Day 17 September 2022 [Internet]. WHO. 2022 [cited 2022 Sep 18]. Available from:
2. Kratz T, Diefenbacher A. Psychopharmacological treatment in older people: avoiding drug interactions and polypharmacy. Deutsches Ärzteblatt International. 2019 Jul;116(29-30):508.
3. Organization WH. Medication without harm [Internet]. World Health Organization; 2017. Available from:
4. Kadivar M, Manookian A, Asghari F, Niknafs N, Okazi A, Zarvani A. Ethical and legal aspects of patient’s safety: A clinical case report. Journal of Medical Ethics and History of Medicine. 2017;10.
5. Entringer S. Carbamazepine [Internet]. [cited 2022 Sep 16]. Available from:
6. Cunha JP. TEGRETOL [Internet]. [cited 2022 Oct 5]. Available from:
7. Subakumar K, Franklin BD, Garfield S. Analysis of the third WHO Global Safety Challenge ‘Medication Without Harm’patient-facing materials: exploratory descriptive study. European Journal of Hospital Pharmacy. 2021 Nov 1;28(e1):e109-14.
8. Before you take it. [Internet]. WHO. 2022 [cited 2022 Sep 18]. Available from:
9. Before you give it [Internet]. WHO. 2022. Available from:
10. Carbamazepine (Oral Route) Print [Internet]. [cited 2022 Oct 5]. Available from:
11. Carbamazepine ER Side Effects by Likelihood and Severity [Internet]. [cited 2022 Oct 5]. Available from:
12. McTier L, Botti M, Duke M. Patient participation in medication safety during an acute care admission. Health Expectations. 2015 Oct;18(5):1744-56.
13. Mohsin-Shaikh S, Garfield S, Franklin BD. Patient involvement in medication safety in hospital: an exploratory study. International Journal of Clinical Pharmacy. 2014 Jun;36(3):657-66.
14. Stöllberger C, Finsterer J. Recurrent venous thrombosis under rivaroxaban and carbamazepine for symptomatic epilepsy. Neurologia Neurochirurgia Polska. 2017;51(2):194-6.
15. Risselada AJ, Visser MJ, Van Roon E. Pulmonary embolism due to interaction between rivaroxaban and carbamazepine. Nederlands Tijdschrift voor Geneeskunde. 2013 Jan 1;157(52):A6568
16. Candeloro M, Eikelboom JW, Chan N, Bhagirath V, Douketis JD, Schulman S. Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort. Research and Practice in Thrombosis and Haemostasis. 2022 Feb;6(2):e12650.
17. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatrics. 2017 Dec;17(1):1-10.
18. Golchin N, Frank SH, Vince A, Isham L, Meropol SB. Polypharmacy in the elderly. J Res Pharm Pract. 2015;4(2):85-8.
19. Medication Without Harm: Real-life stories [Internet]. [cited 2022 Oct 5]. Available from:
IssueVol 10 No 1 (2023): Winter QRcode
SectionCase Report(s)
medication safety; patient safety; carbamazepine; patient participation

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Yazdani Z, Roofeh S. Medication safety and rare side effect of carbamazepine: A case report. NPT. 2023;10(1):4-6.